← Open Payments lookup

ANIL PAREKH: Open Payments

NPI 1154343440 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,991 in 71 payments from 13 companies in 2025. Trend: 2023 $2,478 · 2024 $2,036 · 2025 $1,991

Food & beverage: $1,991
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$691
Neurocrine BioSciences, Inc.7$227
Teva Pharmaceuticals USA, Inc.15$215
Axsome Therapeutics, Inc.5$183
Alkermes, Inc.6$153
Janssen Pharmaceuticals, Inc5$142
Collegium Pharmaceutical, Inc.4$92
Otsuka America Pharmaceutical, Inc.5$79
Vanda Pharmaceuticals Inc.3$70
E.R. Squibb & Sons, L.L.C.3$60

Products named: CAPLYTA, INGREZZA, Auvelity, INVEGA SUSTENNA, UZEDY, Jornay PM, AUSTEDO XR, ARISTADA.

Industry payments across PA — which companies pay providers there.